PB
Peter E. Boyd
Chief People Officer

Peter E. Boyd insider trades: Aquestive Therapeutics (AQST) stock buys and sales

Chief People Officer, Aquestive Therapeutics Last trade Mar 10, 2026 23 Form 4 filings
$124K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2018
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Peter reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 10, 2026AQST↓ Sell$124K
Oct 15, 2025AQST↓ Sell$70K
Sep 26, 2025AQST↓ Sell$63K
Sep 5, 2025AQST↓ Sell$80K
Jun 14, 2022AQST↑ Buy$4K
Jun 8, 2022AQST↑ Buy$2K
Mar 16, 2020AQST↑ Buy$3K
Aug 12, 2019AQST↑ Buy$2K
Nov 21, 2018AQST↑ Buy$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AQST insiders

Open-market trades in the last 12 months

About Peter E. Boyd's insider trades

Peter E. Boyd is Chief People Officer at Aquestive Therapeutics (AQST). Since Nov 21, 2018, Peter has reported 5 open-market purchases worth $14K and 4 sales worth $337K on SEC Form 4. In the last 12 months: 1 sale ($124K).

Their filings also include grants and awards (14 filings), shares withheld for taxes (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AQST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.